Abstract:The SOH1(CP)1 injectable hydrogel system is designed for osteosarcoma‐associated bone defect repair. The system shows high anti‐osteosarcoma efficacy and strong bone repair performance, which is attributed to the mild photothermal effect and ion release activity. The proposed anti‐osteosarcoma and promoting bone defect repair sequential therapy in this system is a promising therapeutic strategy. Osteosarcoma, a common invasive malignant bone disease, presents therapeutic challenges due to the persistent problem of incomplete resection during surgical treatment. This often results in postoperative tumor recurrence and metastasis, and large‐scale bone defects are difficult to self‐repair, seriously affecting patient health. In this study, a dual‐ion doped organic‐inorganic composited SOH1(CP)1 injectable hydrogel system is successfully designed and constructed. This system consists of sericin protein grafted with hydrazide bonds, oxidized chondroitin sulfate, Se and Mg co‐doped HAp nanorods, and polydopamine‐coated CaO2 nanospheres. The system displays strong anti‐tumor activity due to its mild photothermal effects combined with the chemotherapeutic efficacy of SeO32−. Because the degradation behavior of hydrogel matches the bone repair cycle, including the nutritional support of hydrogel skeleton degradation products to promote bone cell proliferation, and the positive regulation of Ca2+, Mg2+, and PO43− released via the degradation of inorganic nanoparticles to promote bone differentiation, the system shows excellent bone defect repair efficacy. Importantly, this system achieves 100% tumor inhibition after 18 days, while ensuring complete bone repair after 12 weeks. Hence, the SOH1(CP)1 injectable hydrogel system, which displays both high anti‐osteosarcoma efficacy and strong bone repair properties, can serve as a new tool for osteosarcoma‐related bone defect repair.

A conductive gelatin methacrylamide hydrogel for synergistic therapy of osteosarcoma and potential bone regeneration

Supramolecular hydrogel-loaded Prussian blue nanoparticles with photothermal and ROS scavenging ability for tumor postoperative treatments

Nanocomposite multifunctional hydrogel for suppressing osteosarcoma recurrence and enhancing bone regeneration

Injectable thermosensitive black phosphorus nanosheet- and doxorubicin-loaded hydrogel for synergistic bone tumor photothermal-chemotherapy and osteogenesis enhancement

Multiple-Effect Combined Hydrogels: "Temporal Regulation" Treatment of Osteosarcoma-Associated Bone Defects with Switchable Hyperthermia and Bioactive Agents

Double-crosslinked Bifunctional Hydrogels with Encapsulated Anti-Cancer Drug for Bone Tumor Cell Ablation and Bone Tissue Regeneration.

An Injectable, Bifunctional Hydrogel with Photothermal Effects for Tumor Therapy and Bone Regeneration

MXene-Based Hydrogels Endow Polyetheretherketone with Effective Osteogenicity and Combined Treatment of Osteosarcoma and Bacterial Infection

Bioactive nanocomposite hydrogel enhances postoperative immunotherapy and bone reconstruction for osteosarcoma treatment

A Unified Therapeutic-Prophylactic Tissue-Engineering Scaffold Demonstrated to Prevent Tumor Recurrence and Overcoming Infection toward Bone Remodeling

Functionalization of an Injectable Self-Healing Ph-Responsive Hydrogel by Incorporating a Curcumin/Polymerized Β-Cyclodextrin Inclusion Complex for Selective Toxicity to Osteosarcoma

Gold Nanorods and Nanohydroxyapatite Hybrid Hydrogel for Preventing Bone Tumor Recurrence Via Postoperative Photothermal Therapy and Bone Regeneration Promotion

Sequentially Degradable Hydrogel-Microsphere Loaded with Doxorubicin and Pioglitazone Synergistically Inhibits Cancer Stemness of Osteosarcoma

Ph-Responsive Hydrogel with Gambogic Acid and Calcium Nanowires for Promoting Mitochondrial Apoptosis in Osteosarcoma

Injectable Hydrogel-Microsphere Construct with Sequential Degradation for Locally Synergistic Chemotherapy

Localized Co-delivery of Doxorubicin, Cisplatin, and Methotrexate by Thermosensitive Hydrogels for Enhanced Osteosarcoma Treatment

Injectable Tumor Microenvironment-Modulated Hydrogels with Enhanced Chemosensitivity and Osteogenesis for Tumor-Associated Bone Defects Closed-Loop Management

3D-Printed Mg-substituted Hydroxyapatite/ Gelatin Methacryloyl Hydrogels Encapsulated with PDA@DOX Particles for Bone Tumor Therapy and Bone Tissue Regeneration

MgSiO3 Fiber Membrane Scaffold with Triggered Drug Delivery for Osteosarcoma Synergetic Therapy and Bone Regeneration

Injectable Magnetic Hydrogel Filler for Synergistic Bone Tumor Hyperthermia Chemotherapy.

An Injectable Hydrogel System with Mild Photothermal Effects Combined with Ion Release for Osteosarcoma‐Related Bone Defect Repair